Clinical Trial Update: Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating fecal microbiota transplantation with ruxolitinib and steroids as upfront treatment for severe acute intestinal graft-versus-host d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)
• Ruxolitinib (Jakafi) (ruxolitinib)
• steroids

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Intestinal GVHD | Phase 1, Phase 2 | Status: TERMINATED